Volastra
1 follower
Volastra Therapeutics, Inc., is developing novel therapies to treat and prevent the formation of metastatic disease. Launched from the laboratory of Dr. Lewis Cantley, along with Drs. Olivier Elemento and Samuel Bakhoum, Volastra has identified the mechanisms by which CIN drives the formation and p... Read more
Org chart
Scott Drutman
Head Of R&d And Chief Medical Officer
Collapse
Jacqueline Gonzalez
Executive Administrative Assistant Office Manager
Jianmin Mao
VP, CMC
Cindy O.
Senior Director, Clinical & Business Operations
Derek Cogan
Senior Vice President, Chemistry
Sarah Bettigole
Vp, Head Of Immunology And Data Science
Linda Lee
Senior Director Clinical Science
Nazario Bosco
Associate Director Of Biology
Adriana Roopnariane
Senior Research Associate
Ryan Schulz
Senior Research Associate
Board & advisors
Stefan Vitorovic
Director
Arjun Balar
Director
Sandi Peterson
Chair
Samuel Bakhoum
Director
Luc Dochez
Director
Amy Schulman
Director
Lewis Cantley
Advisor
David Pellman
Advisor
Duane Compton
Advisor
David Baltimore
Advisor
Karen Vousden
Advisor
Tarun Kapoor
Advisor
Gerard Evan
Advisor
Herald Varmus
Advisor
Hans Clevers
Advisor
Olivier Elemento
Advisor
Offices
Sutro Biopharma
3 followers
Active Motif
3 followers
Dyno Therapeutics
4 followers
Janux Therapeutics
1 follower
Eikon Therapeutics
4 followers
Gilead Sciences
205 followers
Regeneron
172 followers
Illumina
89 followers
Agilent Technologies
96 followers
Verily Life Sciences
49 followers
Alexion Pharmaceuticals
55 followers